SIHUAN PHARMACE (TEL1.SG)
SIHUAN PHARMACE (TEL1.SG) operates in Diversified Metals & Mining.
SIHUAN PHARMACE (TEL1.SG) (TEL1) - Total Liabilities
Latest total liabilities as of December 2023: €6.40 Billion EUR
Based on the latest financial reports, SIHUAN PHARMACE (TEL1.SG) (TEL1) has total liabilities worth €6.40 Billion EUR as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SIHUAN PHARMACE (TEL1.SG) - Total Liabilities Trend (2016–2023)
This chart illustrates how SIHUAN PHARMACE (TEL1.SG)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SIHUAN PHARMACE (TEL1.SG) Competitors by Total Liabilities
The table below lists competitors of SIHUAN PHARMACE (TEL1.SG) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Quantum Helium Limited
LSE:QHE
|
UK | GBX921.18K |
|
NFI Octava SA
WAR:08N
|
Poland | zł25.25 Million |
|
Tix Corp
PINK:TIXC
|
USA | $5.90 Million |
|
TECIL Chemicals and Hydro Power Limited
NSE:TECILCHEM
|
India | ₹228.60 Million |
|
CAMZD
PINK:CAMZD
|
USA | $3.04 Million |
|
Mothercare PLC
LSE:MTC
|
UK | GBX36.40 Million |
|
Bullfrog AI Holdings, Inc. Warrants
NASDAQ:BFRGW
|
USA | $779.04K |
Liability Composition Analysis (2016–2023)
This chart breaks down SIHUAN PHARMACE (TEL1.SG)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SIHUAN PHARMACE (TEL1.SG)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SIHUAN PHARMACE (TEL1.SG) (2016–2023)
The table below shows the annual total liabilities of SIHUAN PHARMACE (TEL1.SG) from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €6.40 Billion | -1.57% |
| 2022-12-31 | €6.50 Billion | +21.61% |
| 2021-12-31 | €5.35 Billion | +72.70% |
| 2020-12-31 | €3.10 Billion | +17.72% |
| 2019-12-31 | €2.63 Billion | -1.49% |
| 2018-12-31 | €2.67 Billion | +18.32% |
| 2017-12-31 | €2.26 Billion | +85.43% |
| 2016-12-31 | €1.22 Billion | -- |